Scholars Central

Conference abstract

Bacillus probiotics as antimicrobials

Authors: Iryna Sorokulova, Darya Starosila, Svetlana Rybalko

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Antibiotic resistance in pathogens was identified as a serious health threat, which is associated with increased morbidity and mortality worldwide. The total economic cost of antibiotic resistance to the US and EU healthcare systems was calculated as $20-35 and EUR 1.5 billion a year correspondingly. The emergence of multiresistant pathogens requires the development of new approaches to their control. Probiotic prophylaxes and therapies are gaining wider acceptance as more scientific data emerge regarding the interaction between pathogen and beneficial microbes in the human intestinal tract and molecular mechanisms of probiotics’ action. Probiotic bacteria which confer beneficial effect for the host and have pronounced antagonistic activity against pathogens is expected to present a clear alternative for control of drug-resistant infections. Bacteria of the Bacillus genus are known as potent producers of a wide variety of antimicrobial compounds. These bacteria are also reputed to promote health benefits on the host. We believe that Bacillus bacteria with high activity against pathogens can be a valuable alternative strategy to control multi-resistant infections. Our study has shown high activity of B. subtilis probiotic strain against a broad spectrum of pathogens, including multiresistant S. aureus, Salmonella, Candida. We also found an inhibitory effect of this strain on influenza virus in vitro and in vivo studies. New peptide P18, produced by B. subtilis strain was isolated and characterized. Peptide P18 was not toxic and completely inhibited influenza virus at concentration 12.5 μg/mL. In animal studies the antiviral effect of P18 was comparable with Tamiflu. In conclusion, our results showed that Bacillus probiotic can be used as a valuable new approach for treatment of bacterial and viral infections.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Food, Nutrition and Population Health.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Food, Nutrition and Population Health
  • SubjectNutrition & Food Science
  • BylineArticles whose byline prints “Iryna Sorokulova”
  • BylineArticles whose byline prints “Darya Starosila”
  • BylineArticles whose byline prints “Svetlana Rybalko”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels